Henry Waxman actually said...

This hearing today has very real implications for patients everywhere. How do we ensure that drug and device companies have the right incent...

We cannot rest on our laurels. We have an obligation to periodically reevaluate and adjust to account for the sweeping changes in the health...

The foundation laid by the Hatch-Waxman Act thirty years ago will continue to be the mechanism by which the government incentivizes developm...

In a biosimilars provision in the Affordable Care Act, we gave 12 years of exclusivity to biologics.